OUTLOOK THERAPEUTICS, INC.

Profile

Company Names

OUTLOOK THERAPEUTICS, INC.
ONCOBIOLOGICS, INC.

Addresses

111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ 08830

485 ROUTE 1 SOUTH, BUILDING F, SUITE 320, ISELIN, NJ 08830

4260 U.S. ROUTE 1, MONMOUTH JUNCTION, NJ 08852

7 CLARKE DRIVE, CRANBURY, NJ 08512

Phone Numbers

609-619-3990
6096193990

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

2011

State Incorporated:

NEW JERSEY

Total Amount Raised:

$179,944,030.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2026-04-23 
$0.00 
$5,000,000.00 
$5,000,000.00 
Equity 
11
2025-01-17 
$0.00 
$31,977,359.00 
$31,977,359.00 
Equity 
10
2024-04-15 
$5,000,002.00 
$13,250,005.00 
$8,250,003.00 
Equity 
9
2024-03-18 
$60,000,000.00 
$159,000,000.00 
$99,000,000.00 
Equity 
8
2022-12-28 
$31,820,000.00 
$31,820,000.00 
$0.00 
Debt 
7
2021-02-03 
$4,013,627.00 
$4,013,627.00 
$0.00 
Equity 
6
2020-06-02 
$16,000,000.00 
$16,000,000.00 
$0.00 
Equity 
5
2020-02-24 
$7,971,155.00 
$7,971,155.00 
$0.00 
Equity 
4
2017-09-11 
$3,262,800.00 
$40,075,000.00 
$36,812,200.00 
Equity 
3
2015-12-08 
$6,345,960.00 
$50,000,000.00 
$43,654,040.00 
Equity 
2
2015-09-28 
$14,480,486.00 
$14,480,486.00 
$0.00 
Equity 
1
2015-06-05 
$31,050,000.00 
$31,050,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GERD 
 
AUFFARTH 
DIRECTOR
OUTLOOK THERAPEUTICS, INC.
KENNETH 
M. 
BAHRT 
EXECUTIVE OFFICER
ONCOBIOLOGICS, INC.
TODD 
 
BRADY 
DIRECTOR
NOVADIGM THERAPEUTICS INC   |  ASMACURE, INC.   |  EVOKE PHARMA INC   |  SEBACIA, INC.   |  ALDEXA THERAPEUTICS, INC.   |  RX GREEN SOLUTIONS LLC   |  ONCOBIOLOGICS, INC.   |  TYROGENEX, INC.   |  THERABRON THERAPEUTICS, INC.   |  AVIDITY BIOSCIENCES LLC   |  GENO LLC   |  ALDEYRA THERAPEUTICS, INC.   |  AVIDITY BIOSCIENCES, INC.   |  VERO BIOTECH INC.   |  HYPERFRAME INC.
TODD 
C. 
BRADY 
DIRECTOR
PARINGENIX INC   |  CANTEX PHARMACEUTICALS, INC.   |  ALDEYRA THERAPEUTICS, INC.   |  ONCOBIOLOGICS, INC.
SCOTT 
 
CANUTE 
DIRECTOR
ALLOCURE INC   |  ONCOBIOLOGICS, INC.
TERRY 
 
DAGNON 
EXECUTIVE OFFICER
OUTLOOK THERAPEUTICS, INC.
ALBERT 
D. 
DYRNESS 
DIRECTOR
ONCOBIOLOGICS, INC.
JEFF 
 
EVANSON 
EXECUTIVE OFFICER
OUTLOOK THERAPEUTICS, INC.
SCOTT 
A. 
GANGLOFF 
EXECUTIVE OFFICER
ONCOBIOLOGICS, INC.
JULIAN 
 
GANGOLLI 
DIRECTOR
OUTLOOK THERAPEUTICS, INC.   |  NAEGIS PHARMACEUTICALS INC.
DONALD 
 
GRIFFITH 
EXECUTIVE OFFICER, DIRECTOR
ONCOBIOLOGICS, INC.   |  SONNET BIOTHERAPEUTICS, INC.   |  SONNET BIOTHERAPEUTICS HOLDINGS, INC.
DONALD 
J. 
GRIFFITH 
DIRECTOR
ONCOBIOLOGICS, INC.
YEZAN 
 
HADDADIN 
DIRECTOR
CHIEF TRUNK CO   |  OUTLOOK THERAPEUTICS, INC.
JULIA 
A. 
HALLER 
DIRECTOR
OUTLOOK THERAPEUTICS, INC.
KURT 
J. 
HILZINGER 
DIRECTOR
ONCOBIOLOGICS, INC.   |  OUTLOOK THERAPEUTICS, INC.
ROBIN 
 
HOKE 
DIRECTOR
ONCOBIOLOGICS, INC.
ANDONG 
 
HUANG 
DIRECTOR
OUTLOOK THERAPEUTICS, INC.
LAWRENCE 
 
KENYON 
EXECUTIVE OFFICER
ONCOBIOLOGICS, INC.
LAWRENCE 
A. 
KENYON 
EXECUTIVE OFFICER, DIRECTOR
TAMIR BIOTECHNOLOGY, INC.   |  OUTLOOK THERAPEUTICS, INC.
STEPHEN 
J. 
MCANDREW 
EXECUTIVE OFFICER
ONCOBIOLOGICS, INC.
PANKAJ 
 
MOHAN 
EXECUTIVE OFFICER, DIRECTOR
ONCOBIOLOGICS, INC.   |  SONNET BIOTHERAPEUTICS, INC.   |  SONNET BIOTHERAPEUTICS HOLDINGS, INC.
FAISAL 
G. 
SUKHTIAN 
DIRECTOR
ONCOBIOLOGICS, INC.   |  OUTLOOK THERAPEUTICS, INC.
JOE 
 
THOMAS 
DIRECTOR
ONCOBIOLOGICS, INC.   |  TRACKMY SOLUTIONS INC.
RANDY 
 
THURMAN 
DIRECTOR
TFF PHARMACEUTICALS, INC.   |  OUTLOOK THERAPEUTICS, INC.
RANDY 
H. 
THURMAN 
DIRECTOR
IKARIA HOLDINGS INC   |  ARNO THERAPEUTICS, INC   |  OUTLOOK THERAPEUTICS, INC.
C. 
RUSSELL 
TRENARY 
EXECUTIVE OFFICER, DIRECTOR
OUTLOOK THERAPEUTICS, INC.
ELIZABETH 
 
YAMASHITA 
EXECUTIVE OFFICER
ONCOBIOLOGICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2026-04-23 
2025-01-27
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-01-17 
2024-04-16
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-04-15 
2024-03-29
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-03-18 
2023-01-06
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2022-12-28 
2023-01-06
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2022-12-28 
2021-02-12
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-02-03 
2020-06-09
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-06-02 
2020-03-11
D
Link
OTHER 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-02-24 
2017-09-25
D
Link
OTHER 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-09-11 
2015-12-23
D
Link
OTHER 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-12-08 
2015-10-13
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-28 
2015-08-10
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
JEFFERIES LLC
2347
NONE
NONE
COVA CAPITAL PARTNERS LLC
109761
NONE
NONE
CITI GROUP GLOBAL MARKETS, INC.
7059
NONE
NONE
JEFFERIES LLC
2347